$ACHV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHIEVE LIFE SCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACHIEVE LIFE SCIENCES, INC.. Get notifications about new insider transactions in ACHIEVE LIFE SCIENCES, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,688 | 0 | 14,062 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,688 | 0 | 9,374 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 12.25 | 4,634 | 56,767 | 64,980 | 69.6 K to 65 K (-6.66 %) |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 9,376 | 0 | 69,614 | 60.2 K to 69.6 K (+15.56 %) |
Dec 02 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | A | 0.00 | 3,750 | 0 | 3,750 | |
Dec 02 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | A | 7.94 | 7,500 | 59,550 | 7,500 | |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | M | 0.00 | 675 | 0 | 1,672 | |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | M | 0.00 | 688 | 0 | 2,062 | |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Payment of Exercise | F | 0.00 | 372 | 0 | 991 | 1.4 K to 991 (-27.29 %) |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Buy | M | 0.00 | 1,363 | 0 | 1,363 | 0 to 1.4 K |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 6,562 | 0 | 16,250 | |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Payment of Exercise | F | 0.00 | 2,951 | 0 | 60,399 | 63.4 K to 60.4 K (-4.66 %) |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 6,562 | 0 | 63,350 | 56.8 K to 63.4 K (+11.56 %) |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 4,593 | 0 | 11,375 | |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 0.00 | 1,293 | 0 | 25,851 | 27.1 K to 25.9 K (-4.76 %) |
Aug 15 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 4,593 | 0 | 27,144 | 22.6 K to 27.1 K (+20.37 %) |
Aug 08 2013 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 10.73 | 5,000 | 53,650 | 5,000 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Buy | M | 10.64 | 2,000 | 21,280 | 5,000 | 3 K to 5 K (+66.67 %) |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 10.73 | 5,000 | 53,650 | 5,000 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Buy | M | 10.64 | 2,000 | 21,280 | 2,000 | 0 to 2 K |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 10.73 | 5,000 | 53,650 | 5,000 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Buy | M | 10.64 | 2,000 | 21,280 | 3,000 | 1,000 to 3 K (+200.00 %) |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 10.73 | 5,000 | 53,650 | 5,000 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Buy | M | 10.64 | 2,000 | 21,280 | 3,000 | 1,000 to 3 K (+200.00 %) |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 10.73 | 5,000 | 53,650 | 5,000 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
May 28 2013 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 10.64 | 2,000 | 21,280 | 9,562 | 7.6 K to 9.6 K (+26.45 %) |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 11.95 | 20,000 | 239,000 | 20,000 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,875 | 0 | 5,625 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 0.00 | 534 | 0 | 22,551 | 23.1 K to 22.6 K (-2.31 %) |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 1,875 | 0 | 23,085 | 21.2 K to 23.1 K (+8.84 %) |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | A | 0.00 | 2,063 | 0 | 2,063 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | A | 11.95 | 4,125 | 49,294 | 4,125 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.00 | 18,750 | 0 | 18,750 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 11.95 | 37,500 | 448,125 | 37,500 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,688 | 0 | 14,062 | |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Payment of Exercise | F | 0.00 | 2,134 | 0 | 56,788 | 58.9 K to 56.8 K (-3.62 %) |
Mar 14 2013 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 4,688 | 0 | 58,922 | 54.2 K to 58.9 K (+8.64 %) |
Oct 19 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 4.11 | 513 | 2,106 | 0 | |
Oct 19 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 4.11 | 513 | 2,106 | 7,562 | 7 K to 7.6 K (+7.28 %) |
Aug 16 2012 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Buy | P | 14.38 | 1,000 | 14,381 | 1,000 | 0 to 1,000 |
Aug 07 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 4.11 | 3,702 | 15,197 | 0 | |
Aug 07 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 4.11 | 3,702 | 15,197 | 7,049 | 3.3 K to 7 K (+110.61 %) |
Aug 07 2012 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 4.11 | 7,000 | 28,736 | 0 | |
Aug 07 2012 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 4.11 | 7,000 | 28,736 | 54,234 | 47.2 K to 54.2 K (+14.82 %) |
Aug 01 2012 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 4.11 | 34,167 | 140,259 | 7,000 | |
Aug 01 2012 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 4.11 | 34,167 | 140,259 | 47,234 | 13.1 K to 47.2 K (+261.48 %) |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 12.56 | 4,000 | 50,240 | 4,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 12.56 | 4,000 | 50,240 | 4,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 12.56 | 4,000 | 50,240 | 4,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | MATTINGLY MARTIN A | Director | Buy | P | 12.46 | 1,000 | 12,460 | 1,000 | 0 to 1,000 |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | A | 12.56 | 4,000 | 50,240 | 4,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Jun 04 2012 | OGXI | ONCOGENEX PHARMACE ... | GOLDSTEIN JACK | Director | Option Exercise | A | 12.56 | 4,000 | 50,240 | 4,000 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.00 | 18,750 | 0 | 18,750 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 13.00 | 37,500 | 487,500 | 37,500 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | Lawrence Cameron William | Principal Accountin ... | Option Exercise | A | 0.00 | 3,250 | 0 | 3,250 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | Lawrence Cameron William | Principal Accountin ... | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | Lawrence Cameron William | Principal Accountin ... | Option Exercise | A | 13.00 | 3,000 | 39,000 | 3,000 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 17,500 | 0 | 17,500 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 13.00 | 15,000 | 195,000 | 15,000 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | CFO | Option Exercise | A | 0.00 | 17,500 | 0 | 17,500 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | CFO | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
May 10 2012 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | CFO | Option Exercise | A | 13.00 | 15,000 | 195,000 | 15,000 | |
Aug 09 2011 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Buy | P | 10.09 | 3,000 | 30,275 | 3,000 | 0 to 3 K |
Aug 17 2011 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 4.11 | 11,210 | 46,018 | 0 | |
Aug 17 2011 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 4.11 | 11,210 | 46,018 | 21,210 | 10 K to 21.2 K (+112.10 %) |
Aug 08 2011 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 4.11 | 10,000 | 41,051 | 17,221 | |
Aug 08 2011 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 4.11 | 10,000 | 41,051 | 10,000 | 0 to 10 K |
Aug 08 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 4.11 | 5,000 | 20,526 | 41,167 | |
Aug 08 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 49,340 | 44.3 K to 49.3 K (+11.28 %) |
Aug 08 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 13,067 | 18.1 K to 13.1 K (-27.67 %) |
Aug 08 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 4.11 | 5,000 | 20,526 | 18,067 | 13.1 K to 18.1 K (+38.26 %) |
Jul 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 3.89 | 952 | 3,702 | 0 | |
Jul 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Option Exercise | M | 3.89 | 2,395 | 9,314 | 0 | |
Jul 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Clendeninn Neil James | Director | Buy | M | 3.89 | 3,347 | 13,016 | 3,347 | 0 to 3.3 K |
Feb 24 2011 | OGXI | ONCOGENEX PHARMACE ... | Lawrence Cameron William | Principal Accountin ... | Option Exercise | M | 3.00 | 1,875 | 5,625 | 3,750 | |
Feb 24 2011 | OGXI | ONCOGENEX PHARMACE ... | Lawrence Cameron William | Principal Accountin ... | Buy | M | 3.00 | 475 | 1,425 | 950 | 475 to 950 (+100.00 %) |
Feb 24 2011 | OGXI | ONCOGENEX PHARMACE ... | Lawrence Cameron William | Principal Accountin ... | Buy | M | 3.00 | 1,400 | 4,200 | 4,450 | 3.1 K to 4.5 K (+45.90 %) |
Jan 04 2011 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | CFO | Option Exercise | A | 16.83 | 35,000 | 589,050 | 35,000 | |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 8,660 | 33,679 | 0 | |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 3,392 | 13,191 | 0 | |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 6,608 | 25,699 | 8,660 | |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 8,660 | 0 | 44,340 | 35.7 K to 44.3 K (+24.27 %) |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 8,660 | 0 | 13,067 | 21.7 K to 13.1 K (-39.86 %) |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 8,660 | 33,679 | 21,727 | 13.1 K to 21.7 K (+66.27 %) |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 16.52 | 3,392 | 56,036 | 8,092 | 11.5 K to 8.1 K (-29.54 %) |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 3,392 | 13,191 | 11,484 | 8.1 K to 11.5 K (+41.92 %) |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 16.52 | 6,608 | 109,164 | 13,067 | 19.7 K to 13.1 K (-33.59 %) |
Jan 06 2011 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 6,608 | 25,699 | 19,675 | 13.1 K to 19.7 K (+50.57 %) |
Dec 16 2010 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 15.97 | 20,000 | 319,400 | 20,000 | |
Dec 16 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 15.97 | 40,000 | 638,800 | 40,000 | |
Dec 16 2010 | OGXI | ONCOGENEX PHARMACE ... | Lawrence Cameron William | Principal Financial ... | Option Exercise | A | 15.97 | 4,000 | 63,880 | 4,000 | |
Dec 10 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 3,467 | 13,483 | 3,392 | |
Dec 10 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 1,533 | 5,962 | 0 | |
Dec 10 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | M | 15.95 | 5,000 | 79,750 | 8,092 | 13.1 K to 8.1 K (-38.19 %) |
Dec 10 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 5,000 | 19,445 | 13,092 | 8.1 K to 13.1 K (+61.79 %) |
Dec 03 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 5,000 | 19,445 | 15,268 | |
Dec 03 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 1,291 | 5,021 | 20,268 | |
Dec 03 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 3,709 | 14,424 | 0 | |
Dec 03 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 35,680 | 30.7 K to 35.7 K (+16.30 %) |
Dec 03 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 13,067 | 18.1 K to 13.1 K (-27.67 %) |
Dec 03 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 5,000 | 19,445 | 18,067 | 13.1 K to 18.1 K (+38.26 %) |
Dec 03 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 16.02 | 5,000 | 80,100 | 13,067 | 18.1 K to 13.1 K (-27.67 %) |
Dec 03 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 5,000 | 19,445 | 18,067 | 13.1 K to 18.1 K (+38.26 %) |
Nov 17 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 5,000 | 19,445 | 3,709 | |
Nov 17 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 5,000 | 19,445 | 1,533 | |
Nov 17 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 30,680 | 25.7 K to 30.7 K (+19.47 %) |
Nov 17 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 13,067 | 18.1 K to 13.1 K (-27.67 %) |
Nov 17 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 5,000 | 19,445 | 18,067 | 13.1 K to 18.1 K (+38.26 %) |
Nov 17 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 15.99 | 5,000 | 79,950 | 8,092 | 13.1 K to 8.1 K (-38.19 %) |
Nov 17 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 5,000 | 19,445 | 13,092 | 8.1 K to 13.1 K (+61.79 %) |
Nov 10 2010 | OGXI | ONCOGENEX PHARMACE ... | Lawrence Cameron William | Principal Financial ... | Buy | P | 15.73 | 650 | 10,225 | 3,050 | 2.4 K to 3.1 K (+27.08 %) |
Nov 02 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 3.89 | 10,000 | 38,890 | 8,709 | |
Nov 02 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 15.45 | 5,000 | 77,250 | 13,067 | 18.1 K to 13.1 K (-27.67 %) |
Nov 02 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 3.89 | 10,000 | 38,890 | 18,067 | 8.1 K to 18.1 K (+123.96 %) |
Aug 27 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Option Exercise | M | 3.89 | 1,761 | 6,849 | 18,709 | |
Aug 27 2010 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President & CEO | Buy | M | 3.89 | 1,761 | 6,849 | 8,067 | 6.3 K to 8.1 K (+27.93 %) |
Aug 10 2010 | OGXI | ONCOGENEX PHARMACE ... | Smith David V | Director | Option Exercise | A | 15.11 | 5,500 | 83,105 | 5,500 | |
Jul 08 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Option Exercise | M | 7.25 | 2,557 | 18,538 | 0 | ||
Jul 08 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Sell | S | 13.02 | 2,557 | 33,292 | 11,000 | 13.6 K to 11 K (-18.86 %) | |
Jul 08 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Buy | M | 7.25 | 2,557 | 18,538 | 13,557 | 11 K to 13.6 K (+23.25 %) | |
Jun 21 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 7.25 | 3,760 | 27,260 | 4,500 | |
Jun 21 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 6.66 | 1,073 | 7,146 | 0 | |
Jun 21 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 0.00 | 4,833 | 0 | 11,000 | 15.8 K to 11 K (-30.52 %) |
Jun 21 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 7.25 | 3,760 | 27,260 | 15,833 | 12.1 K to 15.8 K (+31.14 %) |
Jun 21 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 6.66 | 1,073 | 7,146 | 12,073 | 11 K to 12.1 K (+9.75 %) |
Jun 23 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 7.25 | 943 | 6,837 | 2,557 | |
Jun 23 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Option Exercise | M | 7.25 | 1,000 | 7,250 | 3,500 | |
Jun 23 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Sell | S | 0.00 | 943 | 0 | 11,000 | 11.9 K to 11 K (-7.90 %) |
Jun 23 2010 | OGXI | ONCOGENEX PHARMACE ... | MARTINO MICHAEL A | Director | Buy | M | 7.25 | 943 | 6,837 | 11,943 | 11 K to 11.9 K (+8.57 %) |